This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Siegel, S A Articles by Daddona, P E Search for Related Content PubMed PubMed Citation Articles by Siegel, S A Articles by Daddona, P E

Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria.

Immunobiology R&D, Centocor, Inc., Malvern, Pennsylvania 19355.

ABSTRACT

The effect of antibiotic exposure of phenotypically smooth gram-negative bacteria on binding by the human lipid A-reactive monoclonal antibody HA-1A (trademark of Centocor, Inc.) was examined by liquid-phase immunoassay and by dual-parameter flow cytometry (fluorescence-activated cell sorter [FACS]) analysis. HA-1A exhibited dose-dependent binding to untreated rough gram-negative bacteria such as the Escherichia coli D21F2 Re chemotype strain but little binding to untreated smooth strains such as E. coli O111:B4, or to gram-positive bacteria. However, overnight incubation of E. coli O111:B4 with inhibitory concentrations of ceftazidime produced dose-dependent enhancement of HA-1A binding. Similar augmentation of HA-1A binding was observed when other smooth strains were exposed to cell wall-active agents. Dual-parameter FACS analysis of E. coli O111:B4 exposed overnight to two times the MIC of ceftazidime revealed a decrease in forward light scatter, indicating a reduction in average cell size or bacterial fragmentation, accompanied by a striking increase in lipid A-inhibitable HA-1A binding. Moreover, ceftriaxone, but not gentamicin, produced a marked increase in propidium iodide uptake, indicating an increase in bacterial cell permeability, and a corresponding enhancement of HA-1A binding. Antibiotic-induced enhancement of HA-1A binding to smooth strains of gram-negative bacteria thus appears related to specific alterations in bacterial cell morphology resulting in exposure of the epitope recognized by HA-1A.

This article has been cited by other articles:

• Novo, D. J., Perlmutter, N. G., Hunt, R. H., Shapiro, H. M. (2000). Multiparameter Flow Cytometric Analysis of Antibiotic Effects on Membrane Potential, Membrane Permeability, and Bacterial Counts of Staphylococcus aureus and Micrococcus luteus. Antimicrob. Agents Chemother. 44: 827-834 [Abstract] [Full Text]  
• Helmerhorst, E. J., Maaskant, J. J., Appelmelk, B. J. (1998). Anti-Lipid A Monoclonal Antibody Centoxin (HA-1A) Binds to a Wide Variety of Hydrophobic Ligands. Infect. Immun. 66: 870-873 [Abstract] [Full Text]  
• Healy, D. P., Verst-Brasch, C. L., Clendening, C. E., Neely, A. N., Holder, I. A. (1996). Influence of drug class and dose size on antibiotic-induced endotoxin/IL-6 release and impact on efficacy of anti-endotoxin antibody. Innate Immunity 3: 219-227 [Abstract]  
• Lagrange, P.H., Blanchard, H.S., Felten, A. (1995). Review: Bacterial endotoxin and the human monoclonal antibody HA-IA: specificity, potential mechanisms of action, and limits to its effectiveness. Innate Immunity 2: 371-386 [Abstract]  
• Cross, A.S., Opal, S. (1994). Minireview: Therapeutic intervention in sepsis with antibody to endotoxin: is there a future?. Innate Immunity 1: 57-69 [Abstract]